HLB bioStep Co.,Ltd. (KOSDAQ:278650)

HLB bioStep Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36,549	46,174	68,799	14,873	6,158	8,040
Short-Term Investments	683.2	686.98	1,578	55,000	-	2,550
Trading Asset Securities	-	-	-	27,191	4,235	4,320
Cash & Short-Term Investments	37,233	46,861	70,377	97,064	10,393	14,910
Cash Growth	-28.02%	-33.41%	-27.49%	833.97%	-30.30%	-7.98%
Accounts Receivable	7,435	7,483	3,730	7,009	7,788	6,800
Other Receivables	455.35	1,035	337.14	2,738	662.43	580.36
Receivables	8,272	8,900	4,469	10,065	10,153	8,829
Inventory	1,561	1,511	1,551	1,650	2,920	2,341
Prepaid Expenses	-	132.68	249	133.97	10.39	8.75
Other Current Assets	4,021	5,073	2,767	512.37	5,520	2,490
Total Current Assets	51,087	62,478	79,413	109,426	28,996	28,579
Property, Plant & Equipment	52,144	52,094	40,678	39,626	39,867	26,226
Long-Term Investments	38,807	37,687	44,916	12,811	15,051	12,287
Goodwill	6,490	6,490	1,049	1,049	1,253	1,253
Other Intangible Assets	3,316	3,485	750.69	811.65	722.08	643.24
Long-Term Deferred Tax Assets	3,498	3,100	1,096	2,127	1,302	912.09
Other Long-Term Assets	2,588	2,274	2,841	6,316	7,414	3,495
Total Assets	158,652	168,329	171,714	172,187	94,626	74,215
Accounts Payable	1,429	1,904	1,573	2,050	1,648	1,356
Accrued Expenses	568.48	675.07	438.93	533.51	324.38	282.67
Short-Term Debt	5,270	28,644	54,316	1,689	1,189	210
Current Portion of Long-Term Debt	3,748	3,748	3,448	3,224	3,000	3,000
Current Portion of Leases	389.05	414.96	367.28	398.72	841.66	696.08
Current Income Taxes Payable	1.44	3.11	19.77	352.86	1,444	674.94
Other Current Liabilities	7,454	10,896	4,518	4,527	8,134	9,159
Total Current Liabilities	18,861	46,285	64,682	12,775	16,582	15,379
Long-Term Debt	20,209	1,569	2,017	85,911	10,690	2,690
Long-Term Leases	238.01	320.38	487.93	418.11	583	910.01
Other Long-Term Liabilities	1,988	1,800	643.61	753.88	151.03	28.07
Total Liabilities	42,886	51,515	68,141	99,984	28,265	19,191
Common Stock	8,701	8,673	7,863	7,053	765.19	761.94
Additional Paid-In Capital	86,204	84,861	60,104	31,827	29,661	28,608
Retained Earnings	21,634	23,265	30,727	31,366	34,476	24,585
Treasury Stock	-7,332	-7,332	-1,422	-	-	-960.15
Comprehensive Income & Other	1,826	2,407	4,318	30.94	-315.38	648.22
Total Common Equity	111,033	111,874	101,590	70,278	64,587	53,643
Minority Interest	4,733	4,940	1,983	1,925	1,774	1,381
Shareholders' Equity	115,766	116,814	103,573	72,202	66,361	55,024
Total Liabilities & Equity	158,652	168,329	171,714	172,187	94,626	74,215
Total Debt	29,855	34,696	60,637	91,641	16,304	7,506
Net Cash (Debt)	7,378	12,165	9,740	5,424	-5,911	7,404
Net Cash Growth	-60.72%	24.90%	79.57%	-	-	-20.64%
Net Cash Per Share	87.10	141.83	126.96	77.48	-84.46	107.21
Filing Date Shares Outstanding	77.64	84.2	78.13	70.53	68.87	67.93
Total Common Shares Outstanding	77.64	84.2	78.13	70.53	68.87	68.57
Working Capital	32,227	16,193	14,731	96,651	12,414	13,200
Book Value Per Share	1430.05	1328.74	1300.35	996.42	937.86	782.27
Tangible Book Value	101,227	101,899	99,790	68,417	62,612	51,747
Tangible Book Value Per Share	1303.75	1210.27	1277.31	970.03	909.17	754.61
Land	27,576	27,576	15,253	15,253	13,417	9,744
Buildings	31,001	30,985	24,974	24,280	23,327	12,312
Construction In Progress	70	40	989.4	-	511.28	2,631

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.